Tirzepatide denied for missing prior authorization by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for tirzepatide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Requires Prior Authorization for Tirzepatide

Prior authorization (PA) is BCBS's standard utilization-management gate for tirzepatide. This denial does not mean the drug is inappropriate — it means the plan requires clinical documentation before it will approve coverage. PA denials are among the most commonly overturned denial types because they are procedural, not clinical, and the fix is submitting the right paperwork.

BCBS's PA criteria for tirzepatide will reference the FDA-approved prescribing label and BCBS's own published medical/coverage policy. Both documents define the exact eligibility criteria your case must satisfy — obtain them before building your appeal.

## Your Federal Appeal Rights

Under ACA §2719 and ERISA §503, you have the right to a full internal appeal and, if that fails, an independent external review. The typical window to file an internal appeal is 180 days from receipt of the denial notice. External review is generally available for approximately 4 months after final internal denial. If your condition is urgent or your health could seriously deteriorate while waiting, request expedited review — plans must respond on a compressed timeline.

## Concrete Appeal Steps

1. Obtain the denial letter identifying the specific PA criteria that were not met. 2. Request BCBS's tirzepatide PA criteria and coverage policy — these must be disclosed on request. 3. Have your prescriber resubmit or supplement the PA request with the missing documentation. 4. If resubmission is denied, file a formal written internal appeal with a complete clinical package. 5. On internal denial, request external review through your state's insurance commissioner.

## Documentation to Gather

• Confirmed diagnosis with supporting chart notes and relevant objective findings
• Prior treatment history: names of agents tried, duration, dates, and reasons for discontinuation or inadequate response — in chronological order
• Clinical severity documentation: BMI, comorbidity diagnoses, lab trends (values from your own chart, not thresholds asserted here)
• Prescriber medical-necessity letter: should address each PA criterion by name and map it to a specific chart entry
• Relevant guideline reference: your prescriber should cite the applicable professional society guideline (e.g., the relevant ADA, Obesity Medicine Association, or AACE/ACE guideline) without relying on this document for specific numbers

## Criteria-Mapping Structure

Pull each line of the BCBS PA criteria. For every requirement, document the exact chart fact that satisfies it, the date of that fact, and the source (clinic note, lab report, specialist letter). Submit this as a structured attachment to your appeal letter. A clear one-to-one mapping dramatically increases reversal rates on PA denials.